Covington News

 

 

Alere Acquires Epocal, Inc.

February 4, 2013

WALTHAM, Mass., February 4, 2013 - Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions, announced today that it has acquired Epocal, Inc., a provider of best-in-class technologies that support blood gas and electrolyte testing at the point of care.

Covington Fund II Inc. Series I Announce That Class A Shares Are No Longer Offered For Subscription

January 14, 2013

TORONTO, Jan. 13, 2013 /CNW/ - Covington Capital Corporation ("Covington") and the Board of Directors for Covington Fund II Inc. (the "Fund") today announced that effective December 28, 2012 the Fund would no longer offer Class A shares for sale to investors.  The Fund will remain open to redemptions.

OPKO Health to acquire privately held Cytochroma

January 9, 2013

MARKHAM, ON, Jan. 8, 2013 /CNW/ - Cytochroma today announced that it has entered into a definitive agreement with OPKO Health, Inc. (NYSE:OPK) under which Cytochroma, a privately held pharmaceutical company with operations in Markham, ON and Bannockburn, IL, will be acquired by OPKO.

CounterPath Lists on NASDAQ

July 11, 2012

New York - July 11, 2012 - CounterPath Corporation (the “Company”) commenced trading on the NASDAQ Capital Market under the symbol “CPAH”. The stock is also traded on the TSX under the symbol “CCV”.

The Company’s listing on NASDAQ, which closely followed the completion of a successful (CDN)$3.66 million private placement in June of this year, underscores CounterPath’s steady growth since its inception in 2002.

Covington Strategic Capital Fund Inc. Series I and Series II Announce That Class A Shares Will No Longer Be Offered For Subscription

December 14, 2011

Covington Capital Corporation and the Board of Directors for Covington Strategic Capital Fund Inc. (the “Fund”) today announced that effective December 19, 2011 the Funds will no longer offer Class A shares for sale to either new or existing investors.

Pages